MannKind Corp at JPMorgan Healthcare Conference Transcript

Jan 11, 2024 / 07:15PM GMT
Edwin Zhang JPMorgan Chase&Co.-Moderator

Welcome to the 42nd Annual JPMorgan Healthcare Conference. My name is that Edwin Zhang member of the JPMorgan Health Care team and the moderator for this session today, I would like to introduce you to the team from MannKind Corporation. Please join me in welcoming our presenters, Michael Castagna, CEO, and Steven Binder, CFO.

Michael E. Castagna MannKind Corporation-CEO&Director

Thank you for having us here today, and thank you. We're excited about our ability to really drive shareholder value in 2024 and beyond. Mannkind has been around a long time to an exciting journey, and we have a lot of great things ahead of us. Hopefully, today you'll see a little bit deeper dive on our pipeline, where we're going with our endocrinology business and how we're going to continue to drive future.

Here's our forward-looking statements as I'll be giving some predictions about the future, which may change. You can read this online at MannKind. Our mission is to give

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot